News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Del Global Technologies Corp. Announces the Transfer of Its Dynarad Product Line to JCF Engineering
November 20, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ROSELLE, Ill.--(BUSINESS WIRE)--Del Global Technologies Corp. (OTCBB: DGTC) (“Del Global” or “the Company”) has transferred the Dynarad product line of its Del Medical Imaging business to JCF Engineering, Inc. (“JCF”).
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Manufacturing
Merck barred from making subcutaneous Keytruda in 8 European countries
October 8, 2026
·
2 min read
·
Nick Paul Taylor
Business
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
October 7, 2026
·
2 min read
·
Jef Akst
Deals
Shionogi makes $2B rare disease play with IntraBio buy
October 6, 2026
·
2 min read
·
Tristan Manalac
Licensing
Lilly doubles down on Gate alliance to unlock new drug class with another $870M+ in biobucks
October 5, 2026
·
2 min read
·
Heather McKenzie